Avoidance of surgery for head and neck infantile myofibromatosis using imatinib monotherapy
CLINICAL CASE REPORTS(2022)
摘要
Describe a novel use for a kinase inhibitor, imatinib, in young children with a known activated somatic mutation in PDG FR-beta. Two patients with infantile myofibromatosis treated with imatinib. Case description of evaluation, diagnosis and treatment decisions for infantile myfibromatosis of the head and neck. Description of medical therapy for infantile myofibromatosis in these patients. For function threatening myofibromas of a known genotype, in infants, targeted medical therapy is a treatment option.
更多查看译文
关键词
imatinib,Infantile myofibromatosis,PDGFRB,precision medicine
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要